Acquisition · Activity not yet classified
Kano Laboratories
Transaction overview
Reported acquisition
Announced:
Exact closing date not established.
L Squared Capital Partners reported acquiring Kano Laboratories as a Fund IV platform investment.
Selected source-supported transactions; coverage is incomplete. Announcements do not establish completion or that a deal is still pending. Sponsor activity and operating-business transactions are distinct from adviser acquisitions. Unclassified activity is excluded from adviser-only counts.
Source evidence
- L Squared Acquires Kano Laboratories; Seeks Additional Acquisitions of Leading Specialty Chemicals Businesses Serving the Industrial Sector ↗
L Squared Capital Partners · Published Dec 18, 2024
L Squared announced its Fund IV platform acquisition of Kano, with management and co-investor participation.